Tortoise Investment Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Tortoise Investment Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-711	Closed	-$6K	–	792
2022 Q3	$6K	Buy	+711	New	+$6.29K	﹤0.01%	594
2016 Q1	–	Sell	-338	Closed	-$22K	–	431
2015 Q4	$22K	Buy	+338	New	+$20.9K	0.01%	261
2014 Q3	–	Sell	-500	Closed	-$26K	–	422
2014 Q2	$26K	Buy	+500	New	+$25.6K	0.01%	258

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Tortoise Investment Management's TEVA Position: Q4 2022 in Review

Tortoise Investment Management sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q4 2022, closing a stake of 711 shares — an estimated $6K sold.

Tortoise Investment Management first reported a position in TEVA in Q2 2014 and held it in 3 quarters. The position peaked at $26K in Q2 2014. 421 funds tracked by Wall St. Rank hold TEVA as of Q4 2022.

Tortoise Investment Management reported no remaining Teva Pharmaceutical Industries Limited position as of Q4 2022 after selling out during the quarter.
Tortoise Investment Management sold 711 Teva Pharmaceutical Industries Limited shares in Q4 2022, an estimated $6K.
Tortoise Investment Management first reported a position in Teva Pharmaceutical Industries Limited in Q2 2014 and held it in 3 quarters.
Tortoise Investment Management's Teva Pharmaceutical Industries Limited position peaked at $26K in Q2 2014.
421 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q4 2022.

Based on Tortoise Investment Management's 13F filing for Q4 2022, filed 3 Feb 2023.